Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Asymchem to manufacture oral solid dosage forms including tablets, capsules, and pellets
Subscribe to our email newsletter
Asymchem has declared the issuance of a manufacturing certificate for drug products to its Tianjin 2 site, by the Tianjin branch of the Chinese State Food and Drug Administration (sFDA).
This qualifies Asymchem to manufacture oral solid dosage forms including tablets, capsules, and pellets.
Dr. Hao Hong, CEO, Asymchem, said: We feel drug product capabilities to support all phases of our collaborator’s research, development, and manufacturing are a logical extension of our long-standing capabilities in API development and manufacturing.
Dr. Xiaorong He, Director of Formulation Development for Asymchem said: Operating to the highest technical and regulatory standards is part of the Asymchem culture, and our recent certification demonstrates our commitment to these ideals.
Asymchem Laboratories is a research-based contract manufacturer. The company specializes in the development and compliant manufacturing of API’s and drug products for the pharmaceutical industry.